Storys zum Thema Swiss

Helsinn Healthcare SA

Helsinn and Zealand announce Helsinn's decision to advance the development of elsiglutide into Phase IIb for the prevention of chemotherapy-induced diarrhea

Lugano, Switzerland & Copenhagen, Denmark (ots) - The decision follows promising findings from a Phase IIa Proof-of-Concept study. Helsinn is planning a Phase IIb study with elsiglutide, and study activities are expected to start in H2 2013. The Swiss pharmaceutical group Helsinn, a leading player in the cancer ...

Prionics AG

Prionics and Bio-X Diagnostics form strategic partnership

Schlieren-Zurich, Switzerland (ots) - Prionics, a world leader in farm animal diagnostics, has entered into a strategic partnership with the Belgian company Bio-X Diagnostics to make their innovative diagnostic solutions available to global markets. The collaboration will include distribution, product development and production. Through this partnership, Prionics and Bio-X Diagnostics customers will profit from an ...

BKW Energie AG

Mühleberg nuclear power plant 7 Temporary shutdown for planned maintenance work

Bern (ots) - BKW Inc. plans to carry out scheduled maintenance work on Mühleberg nuclear power plant (KKM). This necessitates a temporary shutdown of the plant, starting on Friday 24 May and ending provisionally on Sunday 26 May 2013. The planned work includes replacing the shaft sealing in a circulation pump. The shaft sealing in the affected pump had already been ...

Helsinn Healthcare SA

Helsinn and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting

Lugano, Switzerland and Woodcliff Lake, NJ, USA (ots) - Data to Be Presented at Annual Meeting of the American Society of Clinical Oncology (ASCO) Helsinn Group and Eisai Inc. announced today top-line results from Helsinn's pivotal clinical studies investigating the oral fixed-dose combination of netupitant and ...

Helsinn Healthcare SA

Helsinn and Vifor Pharma sign Licensing and Distribution agreement for Netupitant-Palonosetron fixed dose combination

Lugano/Glattbrugg, Switzerland (ots) - Helsinn Healthcare SA and Vifor Pharma, announced that the companies have entered into an exclusive license and distribution agreement for netupitant-palonosetron fixed dose combination, a Helsinn product currently in the development stage for the treatment of ...

Billentis

Market report: Global E-Invoice/E-Bill volume to achieve around 20 billion

Wil, Switzerland (ots) - In comparison with paper-based processes, electronic invoice handling processes make it possible to reduce costs by 50-80%. Investments in electronic invoice processing can therefore often be gained back within 6 months. Many companies are already using electronic processes. In 2013 around 20 billion bills/invoices globally and 5.5 billion ...

BKW Energie AG

BKW Board of Directors / Roger Baillod proposed for election

Bacula Systems SA

Bacula Systems Releases Innovative Deduplication Otpimized Volumes Feature

Yverdon-Les-Bains (ots) - With its new Deduplication Volumes feature, Bacula Systems offers the best of deduplication via the convergence of compressing filesystems and fixed-block deduplicating systems technologies. Depending on data, dedupe ratios can be 10:1, 20:1 or even higher. Yverdon-Les-Bains, Switzerland - Bacula Systems® (http://www.baculasystems.com/), the ...

BKW Energie AG

2

BKW Inc. / Important Personnel Decisions for Strategy Implementation / MONICA DELL'ANNA AND RENATO STURANI APPOINTED TO BKW GROUP EXECUTIVE BOARD

Jacobs Foundation

Olaf von Maydell is appointed to the Board of Trustees of the Jacobs Foundation

Zurich (ots) - Dr. Olaf von Maydell has been appointed to the Board of Trustees of the Jacobs Foundation, effective May 1, 2013. A tax consultant who holds a PhD in agricultural economics, Dr. von Maydell is a partner in the Schomerus & Partner tax consulting firm in Berlin. He served as General Manager of the Max Planck Institute for Human Development in Berlin from ...

WISeKey SA

WISeKey goes further in Luxury Brand protection with an innovative mobile experience

Basel, Switzerland (ots) - WISeKey's anti-counterfeiting technologies revolutionized the high-precision timepiece industry when first launched with Hublot at BaselWorld in 2009 and the security company further enhances the technology to better "empower brands, consumers, distributors, governments and vendors to distinguish genuine goods from illegal imitations". With ...

WISeKey SA

WISeKey receives strategic investment from GJC, Grupo Jaime Câmara, leading Brazilian media group and creates a new JV "WISeKey Liber"

Geneva, Switzerland/Lima, Peru (ots) - WISeKey and GJC, Grupo Jaime Câmara, two World Economic Forum Global Growth Companies have entered into a Joint Venture Agreement, aiming at the creation of a new company with the name WISeKey Liber expanding WISeKey's global footprint to Latin America and Iberia. WISeKey's ...

Helsinn Healthcare SA

Helsinn and DARA Announce U.S. Launch of Gelclair®, an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis

Lugano, Switzerland/Raleigh, N.C. (ots) - The Swiss pharmaceutical Helsinn Group, a leading player in the cancer supportive care arena, announced today that DARA BioSciences, Inc., a U.S. specialty pharmaceutical company focused on oncology and oncology supportive care products, has launched Gelclair® into the U.S. ...

WISeKey SA

WISeKey and Qwant launch a Joint Venture WISeQwant providing Next Generation ID based Social Mobile Search for Fan Ecosystems

Geneva, Switzerland/Paris, France (ots) - Following on the partnership announced last year WISeKey and Qwant have launched a Joint Venture with the name WISeQwant.com associating WISekey's digital identity management, mobile apps and encryption with Qwant Search technologies. WISeQwant defines a new paradigm for ...

Helsinn Healthcare SA

Helsinn Group enters into a new partnership with Healthcare Businesswomen's Association (HBA)

Lugano, Switzerland (ots) - Helsinn Group has entered into a new partnership with Healthcare Businesswomen's Association (HBA). HBA is the premier catalyst for the leadership development of women, to further the advancement and impact of women in healthcare worldwide. HBA accomplishes this by providing educational opportunities to develop cutting-edge industry ...

Franke Group

Franke to acquire Swiss tap manufacturer KWC

Aarburg (ots) - Franke agreed to buy Swiss tap manufacturer KWC, broadens its core competence in water technology and further strengthens its presence in Switzerland. Franke agreed to buy the Swiss tap manufacturer KWC, based in Unterkulm, from IK Investment Partners. The transaction is subject to regulatory approval. KWC will become an independent ...

WISeKey SA

WISeKey and FC Barcelona Launch "FCB connect": One App, One Ecosystem for Millions of Followers

Geneva (ots) - Millions of fans and followers worldwide for football clubs, dozens of players with several social media accounts, leading to a fragmented communication ecosystem between clubs, players and people living their passion. Today, Information security specialist WISeKey and Football Club Barcelona launched ...

JTI Japan Tobacco International AG

JTI Certified Top Employer Europe 2013

Geneva, Switzerland (ots) - Belgium, France, Italy, Netherlands, Poland, Switzerland, United Kingdom, Czech Republic, Denmark & Greece awarded by the CRF Institute Japan Tobacco International (JTI) today received the Top Employer Europe 2013 certification during an awards ceremony held at the Park Plaza in London. Ten JTI offices were recognized for their excellence in human resources management by the CRF Institute as a ...

Museum der Kulturen Basel

Museum der Kulturen Basel, Switzerland - Exhibition 22 March to 29 September 2013: What next? Insurrection of things in the Amazon (PICTURE)

BKW Energie AG

2013 Annual Press Conference - Solid business performance despite difficult market conditions - BKW well-equipped for the future

Bern (ots) - The BKW Group recorded a solid operating profit in 2012 despite the challenging economic and regulatory environment. Both the energy and grid businesses contributed to this positive development, which was supported by higher production volumes from nuclear power plants and renewable energies, the good ...

BKW Energie AG

Board of Directors of BKW Inc. Ueli Dietiker steps down

Bern (ots) - By agreement with the Board of Directors of BKW, Ueli Dietiker has decided to step down at the Annual General Meeting on 17 May 2013. His resignation was made in view of his commitment to Swisscom AG. By deciding to step down, Ueli Dietiker eliminates any potential conflict of interests between his BKW mandate and his position at Swisscom. Dietiker has been a member of the BKW Board of Directors since his ...

Raiffeisen Schweiz

Raiffeisen subsidiary Notenstein Private Bank Ltd buys stake in EFG Financial Products Holding Ltd

St. Gallen (ots) - Raiffeisen subsidiary, Notenstein Private Bank Ltd, is increasing its equity stake in EFG Financial Products Holding Ltd to 22.75 per cent. It will also be issuing structured investment products guaranteed by Raiffeisen Switzerland Cooperative for the Swiss home market as part of a white-labeling partnership with EFG Financial Products Ltd, a Swiss ...

Solution Providers

Solution Providers releases paper on Singapore asset management industry

Zurich (ots) - Solution Providers has released a paper on the Singapore asset management industry and sees a bright future for Singapore as a hub for the region. Based on extensive research and analysis, supplemented by structured interviews with key industry figures, the industry has sound foundations for the future. In its paper, Solution Providers states that the ...

AmVac AG

AmVac's Vaccine against RSV Attains Next Milestone

Zug (ots) - AmVac AG announces new preclinical data on its vaccine candidate AMV602 for the prevention of infections caused by respiratory syncytial virus (RSV). Last fall, the company selected the candidate as the most promising for further development among a range of potential leads. In preclinical studies, renowned RSV expert Prof.ssa Grazia Cusi and her team at the University of Siena, Italy, have now confirmed the ...